Front Row Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-231
| Closed | -$33K | – | 737 |
|
|
2024
Q2 | $33K | Buy |
231
+2
| +0.9% | +$285 | 0.01% | 321 |
|
|
2024
Q1 | $29.4K | Buy |
+229
| New | +$29.4K | 0.01% | 328 |
|
|
2023
Q4 | – | Sell |
-241
| Closed | -$21.9K | – | 704 |
|
|
2023
Q3 | $21.9K | Buy |
241
+89
| +59% | +$8.09K | 0.01% | 362 |
|
|
2023
Q2 | $12K | Sell |
152
-16
| -10% | -$1.26K | 0.01% | 483 |
|
|
2023
Q1 | $13K | Sell |
168
-4
| -2% | -$310 | 0.01% | 467 |
|
|
2022
Q4 | $12K | Sell |
172
-78
| -31% | -$5.44K | 0.01% | 462 |
|
|
2022
Q3 | $13K | Sell |
250
-48
| -16% | -$2.5K | 0.01% | 455 |
|
|
2022
Q2 | $17K | Sell |
298
-4
| -1% | -$228 | 0.01% | 427 |
|
|
2022
Q1 | $17K | Sell |
302
-80
| -21% | -$4.5K | 0.01% | 452 |
|
|
2021
Q4 | $21K | Sell |
382
-2
| -0.5% | -$110 | 0.01% | 417 |
|
|
2021
Q3 | $18K | Sell |
384
-4
| -1% | -$188 | 0.01% | 447 |
|
|
2021
Q2 | $20K | Buy |
388
+18
| +5% | +$928 | 0.01% | 422 |
|
|
2021
Q1 | $13K | Buy |
370
+8
| +2% | +$281 | 0.01% | 496 |
|
|
2020
Q4 | $13K | Sell |
362
-16
| -4% | -$575 | 0.01% | 464 |
|
|
2020
Q3 | $13K | Buy |
+378
| New | +$13K | 0.01% | 456 |
|
|
2020
Q1 | – | Sell |
-88
| Closed | -$3K | – | 1022 |
|
|
2019
Q4 | $3K | Hold |
88
| – | – | ﹤0.01% | 730 |
|
|
2019
Q3 | $2K | Sell |
88
-88
| -50% | -$2K | ﹤0.01% | 792 |
|
|
2019
Q2 | $4K | Hold |
176
| – | – | ﹤0.01% | 660 |
|
|
2019
Q1 | $5K | Sell |
176
-192
| -52% | -$5.46K | ﹤0.01% | 594 |
|
|
2018
Q4 | $8K | Sell |
368
-44
| -11% | -$957 | 0.01% | 441 |
|
|
2018
Q3 | $9 | Sell |
412
-194
| -32% | -$4 | 0.01% | 443 |
|
|
2018
Q2 | $15 | Buy |
606
+192
| +46% | +$5 | 0.01% | 386 |
|
|
2018
Q1 | $10K | Buy |
414
+316
| +322% | +$7.63K | 0.01% | 441 |
|
|
2017
Q4 | $3K | Buy |
+98
| New | +$3K | ﹤0.01% | 618 |
|